Hamilton Morris

In a welcomed throwback to the days before psychedelic use and research was considered a forbidden topic, the conference “Horizons: Perspectives On Psychedelics” in New York City is an incredible testimony to where the field of psychedelic therapy, and the industry as a whole, is...

The state of Pennsylvania is poised to become a leader in psychedelic research after a bill known as the Public Health Benefits of Psilocybin Act was introduced recently in the House of Representatives. The proposed legislation looks to create a framework for clinical studies of psilocybin,...

Ketamine, an FDA-approved anesthetic drug, has recently become the star of the psychedelic medicine movement.  As psychedelics like psilocybin and MDMA draw closer to FDA approval for the treatment of a variety of mental health indications, ketamine is paving the way for the development of a...